KRTX - Karuna Therapeutics to Announce Second Quarter 2023 Financial Results and Provide General Business Update on Thursday August 3 2023
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that it will host a live conference call and webcast on Thursday, August 3, 2023 at 8:00 a.m. ET to review second quarter 2023 financial results and provide a general business update.
A live webcast of the presentation will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com . A replay of the webcast will also be archived for up to 30 days on Karuna’s website following the completion of the event.
About Karuna Therapeutics
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20230720981065/en/
Investors:
Alexis Smith
+1 (518) 338-8990
asmith@karunatx.com
Media:
Bob Josefsberg
+1 (646) 734-3584
bjosefsberg@karunatx.com